Targeted metabolomic analysis of nitric oxide/L-arginine pathway metabolites in dementia: association with pathology, severity, and structural brain changes

Documenti analoghi

• Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS)
  di: Krzystek-Korpacka, Małgorzata, et al.
  Pubblicazione: (2019)
• Quantitative Analysis of l-Arginine, Dimethylated Arginine Derivatives, l-Citrulline, and Dimethylamine in Human Serum Using Liquid Chromatography–Mass Spectrometric Method
  di: Fleszar, Mariusz G., et al.
  Pubblicazione: (2018)
• Tumor location determines midkine level and its association with the disease progression in colorectal cancer patients: a pilot study
  di: Krzystek-Korpacka, Malgorzata, et al.
  Pubblicazione: (2012)
• Transcriptional and Metabolomic Analysis of L-Arginine/Nitric Oxide Pathway in Inflammatory Bowel Disease and Its Association with Local Inflammatory and Angiogenic Response: Preliminary Findings
  di: Krzystek-Korpacka, Małgorzata, et al.
  Pubblicazione: (2020)
• Esophageal Squamous Cell Carcinoma Is Accompanied by Local and Systemic Changes in L-arginine/NO Pathway
  di: Bednarz-Misa, Iwona, et al.
  Pubblicazione: (2020)